LLMpediaThe first transparent, open encyclopedia generated by LLMs

Carol Greider

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 47 → Dedup 4 → NER 2 → Enqueued 1
1. Extracted47
2. After dedup4 (None)
3. After NER2 (None)
Rejected: 2 (not NE: 2)
4. Enqueued1 (None)
Similarity rejected: 1
Carol Greider
NameCarol Greider
Birth dateApril 15, 1961
Birth placeSan Diego, California, United States
NationalityAmerican
FieldsMolecular biology, Genetics, Cell biology
InstitutionsJohns Hopkins University, Cold Spring Harbor Laboratory, University of California, Berkeley
Alma materUniversity of California, Santa Barbara; University of California, Berkeley
Known forDiscovery of telomerase
AwardsNobel Prize in Physiology or Medicine (2009), Lasker Award (2006)

Carol Greider

Carol Greider is an American molecular biologist noted for her work on chromosome biology, telomere structure, and telomerase. She co-discovered telomerase and characterized its role in maintaining telomere length, a finding that reshaped research in aging and cancer. Her career spans major research centers including Johns Hopkins University and Cold Spring Harbor Laboratory, culminating in shared recognition with the Nobel Prize and other major scientific awards.

Early life and education

Greider was born in San Diego and grew up in a family with scientific and artistic influences; her early years were shaped by exposure to nature and education in Southern California. She attended the University of California, Santa Barbara where she earned a Bachelor of Arts, and then pursued graduate studies at the University of California, Berkeley under the mentorship of prominent molecular biologists. At Berkeley she worked in laboratories connected to researchers associated with Molecular Biology programs and interacted with faculty from institutions such as Stanford University, Massachusetts Institute of Technology, and Harvard University through seminars and collaborative projects. Her doctoral and postdoctoral training placed her in networks that included scientists linked to National Institutes of Health, Salk Institute for Biological Studies, and research consortia involving the Cold Spring Harbor Laboratory.

Research and career

Greider began her independent research career with appointments at leading biomedical centers. Early positions included work at Cold Spring Harbor Laboratory where she joined a community of geneticists and cell biologists who had ties to historic figures like James Watson and laboratories associated with the Phage Group. She later moved to faculty positions at Johns Hopkins University School of Medicine and took on a laboratory that investigated telomeric DNA using techniques related to those developed in groups at University of California, San Diego and Scripps Research. Her lab adopted molecular cloning, biochemical assays, and cellular models drawn from methodologies refined at EMBL, Max Planck Institute, and other research institutes. Throughout her career Greider collaborated with investigators from institutions such as Princeton University, University of Cambridge, and Columbia University, advancing studies on DNA replication, RNA biology, and chromosomal stability. Her mentorship produced trainees who later joined faculties at places including Yale University, University of Chicago, and University of California, San Francisco.

Discovery of telomerase and telomeres

In work conducted in the mid-1980s and early 1990s, Greider and collaborators identified an enzymatic activity that adds nucleotide repeats to chromosome ends. This discovery built on prior observations of repetitive sequences at telomeres from researchers associated with Elizabeth Blackburn and groups studying Tetrahymena thermophila genetics. Using biochemical fractionation and hybridization methods akin to those used in labs at Cold Spring Harbor Laboratory and University of California, Berkeley, she and colleagues purified the ribonucleoprotein enzyme now known as telomerase. Their experiments demonstrated that telomerase contains an RNA component and a catalytic reverse transcriptase, bridging concepts from research on reverse transcriptase enzymes originally characterized by scientists at Rockefeller University and laboratories engaged with Howard Temin and David Baltimore legacies. The identification of telomerase explained how cells maintain telomere length despite the end-replication problem first articulated by theoretical work tied to researchers at University of Cambridge and biochemical studies in European Molecular Biology Laboratory contexts. Subsequent studies from Greider’s group and collaborating labs at institutions such as University of Michigan, University of Pennsylvania, and Cold Spring Harbor Laboratory linked telomere shortening to replicative senescence, genome instability, and tumorigenesis, fostering translational research pursued at biomedical centers including Dana-Farber Cancer Institute and pharmaceutical collaborations with industry laboratories.

Awards and honors

Greider’s contributions earned numerous prizes and memberships in prestigious organizations. She shared the Nobel Prize in Physiology or Medicine in 2009, an honor reflecting work recognized by committees connected to the Karolinska Institute. Earlier recognition included the Alfred P. Sloan Foundation fellowships, the Lasker~Koshland Special Achievement Award in Medical Science, and the National Academy of Sciences membership. She received awards and lectureships offered by societies such as the American Society for Cell Biology, the American Association for the Advancement of Science, and the American Academy of Arts and Sciences. Honorary degrees and prizes came from universities and foundations including Columbia University, Harvard University, and philanthropic organizations that support biomedical research.

Personal life and legacy

Greider has balanced a scientific career with family life and public engagement on issues linking basic science to health policy. Her legacy includes the widespread incorporation of telomere biology into research programs at universities such as University of California, San Francisco and institutes like Salk Institute for Biological Studies, influencing fields as diverse as developmental biology, oncology, and regenerative medicine. The discovery of telomerase catalyzed the formation of biotech ventures and clinical research initiatives at centers including Memorial Sloan Kettering Cancer Center and spurred collaborations between academia and industry exemplified by partnerships with pharmaceutical companies and translational networks. Her mentees and collaborators continue to lead laboratories at institutions such as Johns Hopkins University, Cold Spring Harbor Laboratory, and Stanford University, perpetuating a research lineage that intersects with major scientific movements and institutions worldwide.

Category:American molecular biologists Category:Nobel laureates in Physiology or Medicine